Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Tränkle C[au]:

A review of PCSK9 inhibition and its effects beyond LDL receptors. Dixon DL et al. J Clin Lipidol. (2016)

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction. Van Tassell BW et al. Circ Heart Fail. (2018)

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics. Carbone S et al. Diabetes Obes Metab. (2018)

Search results

Items: 1 to 50 of 109

1.

Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy.

Canada JM, Thomas GK, Trankle CR, Carbone S, Billingsley H, Van Tassell BW, Evans RK, Garten R, Weiss E, Abbate A.

Cardiooncology. 2020 Feb 28;6:2. doi: 10.1186/s40959-020-0058-1. eCollection 2020.

2.

Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.

Abbate A, Trankle CR, Buckley LF, Lipinski MJ, Appleton D, Kadariya D, Canada JM, Carbone S, Roberts CS, Abouzaki N, Melchior R, Christopher S, Turlington J, Mueller G, Garnett J, Thomas C, Markley R, Wohlford GF, Puckett L, Medina de Chazal H, Chiabrando JG, Bressi E, Del Buono MG, Schatz A, Vo C, Dixon DL, Biondi-Zoccai GG, Kontos MC, Van Tassell BW.

J Am Heart Assoc. 2020 Mar 3;9(5):e014941. doi: 10.1161/JAHA.119.014941. Epub 2020 Mar 3.

3.

Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double-Blinded, Placebo-Controlled CITRIS-AF Pilot Study.

Trankle CR, Puckett L, Swift-Scanlan T, DeWilde C, Priday A, Sculthorpe R, Ellenbogen KA, Fowler A, Koneru JN.

J Am Heart Assoc. 2020 Feb 4;9(3):e014213. doi: 10.1161/JAHA.119.014213. Epub 2020 Jan 30.

4.

Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors.

Canada JM, Trankle CR, Carbone S, Buckley LF, Chazal M, Billingsley H, Evans RK, Garten R, Van Tassell BW, Kadariya D, Mauro A, Toldo S, Mezzaroma E, Arena R, Hundley WG, Grizzard JD, Weiss E, Abbate A.

Am J Cardiol. 2020 Mar 15;125(6):988-996. doi: 10.1016/j.amjcard.2019.12.019. Epub 2019 Dec 26.

PMID:
31928717
5.

Clopidogrel Responsiveness in Patients With Decompensated Cirrhosis of the Liver Undergoing Pre-Transplant PCI.

Trankle CR, Vo C, Martin E, Puckett L, Siddiqui MS, Brophy DF, Stravitz T, Guzman LA.

JACC Cardiovasc Interv. 2020 Mar 9;13(5):661-663. doi: 10.1016/j.jcin.2019.08.038. Epub 2019 Dec 25. No abstract available.

PMID:
31883726
6.

Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.

Van Tassell BW, Westman P, Trankle C, Johns S, Kadariya D, Buckley L, Carbone S, Abbate A, Moeller FG.

J Cardiovasc Pharmacol. 2019 Dec;74(6):528-534. doi: 10.1097/FJC.0000000000000740.

PMID:
31809403
7.

Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions.

van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Kadariya D, Trankle CR, Wohlford G, Buckley L, Del Buono MG, Billingsley H, Viscusi M, Tchoukina I, Shah KB, Arena R, Van Tassell B, Abbate A.

Am J Cardiol. 2020 Jan 1;125(1):76-81. doi: 10.1016/j.amjcard.2019.09.036. Epub 2019 Oct 10.

PMID:
31703805
8.

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.

Carbone S, Billingsley HE, Canada JM, Kadariya D, Medina de Chazal H, Rotelli B, Potere N, Paudel B, Markley R, Dixon DL, Trankle CR, Van Tassell BW, Celi FS, Abbate A.

JACC Basic Transl Sci. 2019 Aug 26;4(4):563-565. doi: 10.1016/j.jacbts.2019.04.001. eCollection 2019 Aug. No abstract available.

9.

Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).

Trankle CR, Wohlford G, Buckley LF, Kadariya D, Ravindra K, Markley R, Park TS, Potere N, Van Tassell BW, Abbate A.

J Cardiovasc Pharmacol. 2019 Sep;74(3):266-269. doi: 10.1097/FJC.0000000000000706.

PMID:
31356537
10.

Metabolic modulation predicts heart failure tests performance.

Contaifer D Jr, Buckley LF, Wohlford G, Kumar NG, Morriss JM, Ranasinghe AD, Carbone S, Canada JM, Trankle C, Abbate A, Van Tassell BW, Wijesinghe DS.

PLoS One. 2019 Jun 20;14(6):e0218153. doi: 10.1371/journal.pone.0218153. eCollection 2019.

11.

Novel BQCA- and TBPB-Derived M1 Receptor Hybrid Ligands: Orthosteric Carbachol Differentially Regulates Partial Agonism.

Schramm S, Agnetta L, Bermudez M, Gerwe H, Irmen M, Holze J, Littmann T, Wolber G, Tränkle C, Decker M.

ChemMedChem. 2019 Jul 17;14(14):1349-1358. doi: 10.1002/cmdc.201900283. Epub 2019 Jul 3.

PMID:
31166078
12.

Left Ventricular Assist Device Outflow Graft Compression: Incidence, Clinical Associations and Potential Etiologies.

Trankle CR, Grizzard JD, Shah KB, Rezai Gharai L, Dana F, Kang MS, Andreae AE, Desai K, Quader MA, Gertz ZM.

J Card Fail. 2019 Jul;25(7):545-552. doi: 10.1016/j.cardfail.2019.05.004. Epub 2019 May 11.

PMID:
31085224
13.

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities.

Grinnan D, Trankle C, Andruska A, Bloom B, Spiekerkoetter E.

Pulm Circ. 2019 Jan-Mar;9(1):2045894019832226. doi: 10.1177/2045894019832226.

14.

Potential role for interleukin-1 in the cardio-renal syndrome.

Buckley LF, Canada JM, Carbone S, Trankle CR, Kadariya D, Billingsley H, Wohlford GF, Kirkman DL, Abbate A, Van Tassell BW.

Eur J Heart Fail. 2019 Mar;21(3):385-386. doi: 10.1002/ejhf.1403. Epub 2019 Jan 22. No abstract available.

15.

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.

van Wezenbeek J, Canada JM, Ravindra K, Carbone S, Trankle CR, Kadariya D, Buckley LF, Del Buono M, Billingsley H, Viscusi M, Wohlford GF, Arena R, Van Tassell B, Abbate A.

Front Cardiovasc Med. 2018 Dec 21;5:178. doi: 10.3389/fcvm.2018.00178. eCollection 2018.

16.

Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.

Canada JM, Abbate A, Collen R, Billingsley H, Buckley LF, Carbone S, Trankle CR, Idowu MO, Kadariya D, Van Tassell B, Sanyal AJ, Siddiqui MS.

Am J Cardiol. 2019 Feb 1;123(3):466-473. doi: 10.1016/j.amjcard.2018.10.027. Epub 2018 Nov 6.

17.

The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

Klaschik K, Hauke J, Neidhardt G, Tränkle C, Surowy HM, Heilmann-Heimbach S, Rappl G, Mangold E, Arnold N, Niederacher D, Sutter C, Burwinkel B, Engel C, Wappenschmidt B, Meindl A, Ernst C, Weber-Lassalle K, Weber-Lassalle N, Schmidt S, Borde J, Schmutzler RK, Hahnen E, Pohl-Rescigno E.

Int J Cancer. 2019 Apr 1;144(7):1761-1763. doi: 10.1002/ijc.32016. Epub 2019 Jan 6. No abstract available.

18.

IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.

Trankle CR, Canada JM, Kadariya D, Markley R, De Chazal HM, Pinson J, Fox A, Van Tassell BW, Abbate A, Grinnan D.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):381-384. doi: 10.1164/rccm.201809-1631LE. No abstract available.

19.

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.

Van Tassell BW, Trankle CR, Canada JM, Carbone S, Buckley L, Kadariya D, Del Buono MG, Billingsley H, Wohlford G, Viscusi M, Oddi-Erdle C, Abouzaki NA, Dixon D, Biondi-Zoccai G, Arena R, Abbate A.

Circ Heart Fail. 2018 Aug;11(8):e005036. doi: 10.1161/CIRCHEARTFAILURE.118.005036.

20.

Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.

Trankle CR, Canada JM, Cei L, Abouzaki N, Oddi-Erdle C, Kadariya D, Christopher S, Viscusi M, Del Buono M, Kontos MC, Arena R, Van Tassell B, Abbate A.

Am J Cardiol. 2018 Oct 15;122(8):1366-1370. doi: 10.1016/j.amjcard.2018.07.002. Epub 2018 Jul 20.

21.

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction.

Carbone S, Canada JM, Buckley LF, Trankle CR, Billingsley HE, Dixon DL, Mauro AG, Dessie S, Kadariya D, Mezzaroma E, Buzzetti R, Arena R, Van Tassell BW, Toldo S, Abbate A.

JACC Basic Transl Sci. 2017 Oct 30;2(5):513-525. doi: 10.1016/j.jacbts.2017.06.009. eCollection 2017 Oct.

22.

Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.

Van Tassell BW, Lipinski MJ, Appleton D, Roberts CS, Kontos MC, Abouzaki N, Melchior R, Mueller G, Garnett J, Canada J, Carbone S, Buckley LF, Wohlford G, Kadariya D, Trankle CR, Oddi Erdle C, Sculthorpe R, Puckett L, DeWilde C, Shah K, Angiolillo DJ, Vetrovec G, Biondi-Zoccai G, Arena R, Abbate A.

Clin Cardiol. 2018 Aug;41(8):1004-1008. doi: 10.1002/clc.22988. Epub 2018 Aug 17.

23.

Characterization of methanthelinium binding and function at human M1-M5 muscarinic acetylcholine receptors.

Irmen M, Holze J, Bödefeld T, Tränkle C.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Oct;391(10):1037-1052. doi: 10.1007/s00210-018-1525-1. Epub 2018 Jun 24.

PMID:
29938305
24.

Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads.

Trankle CR, Gertz ZM, Koneru JN, Kasirajan V, Nicolato P, Bhardwaj HL, Ellenbogen KA, Kalahasty G.

Pacing Clin Electrophysiol. 2018 Jul;41(7):845-853. doi: 10.1111/pace.13369. Epub 2018 Jun 4. Review.

PMID:
29757467
25.

Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.

Buckley LF, Carbone S, Trankle CR, Canada JM, Erdle CO, Regan JA, Viscusi MM, Kadariya D, Billingsley H, Arena R, Abbate A, Van Tassell BW.

J Cardiovasc Pharmacol. 2018 Jul;72(1):68-70. doi: 10.1097/FJC.0000000000000591.

26.

Internal Versus External Compression of a Left Ventricular Assist Device Outflow Graft: Diagnosis With Intravascular Ultrasound and Treatment With Stenting.

Trankle CR, Quader MA, Grizzard JD, Tang DG, Shah KB, Paris K, Shepard CK, Gertz ZM.

Circ Heart Fail. 2018 May;11(5):e004959. doi: 10.1161/CIRCHEARTFAILURE.118.004959. No abstract available.

PMID:
29695382
27.

Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.

Abouzaki NA, Christopher S, Trankle C, Van Tassell BW, Carbone S, Mauro AG, Buckley L, Toldo S, Abbate A.

J Cardiovasc Pharmacol. 2018 Jun;71(6):375-379. doi: 10.1097/FJC.0000000000000583.

28.

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.

Carbone S, Canada JM, Billingsley HE, Kadariya D, Dixon DL, Trankle CR, Buckley LF, Markley R, Vo C, Medina de Chazal H, Christopher S, Buzzetti R, Van Tassell BW, Abbate A.

Diabetes Obes Metab. 2018 Aug;20(8):2014-2018. doi: 10.1111/dom.13309. Epub 2018 Apr 23.

29.

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.

Buckley LF, Canada JM, Del Buono MG, Carbone S, Trankle CR, Billingsley H, Kadariya D, Arena R, Van Tassell BW, Abbate A.

ESC Heart Fail. 2018 Apr;5(2):372-378. doi: 10.1002/ehf2.12235. Epub 2018 Jan 18.

30.

Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).

Van Tassell BW, Canada J, Carbone S, Trankle C, Buckley L, Oddi Erdle C, Abouzaki NA, Dixon D, Kadariya D, Christopher S, Schatz A, Regan J, Viscusi M, Del Buono M, Melchior R, Mankad P, Lu J, Sculthorpe R, Biondi-Zoccai G, Lesnefsky E, Arena R, Abbate A.

Circ Heart Fail. 2017 Nov;10(11). pii: e004373. doi: 10.1161/CIRCHEARTFAILURE.117.004373.

31.

Hypoxemia Due to Patent Foramen Ovale in the Setting of New Right Hemidiaphragmatic Paralysis.

Trankle CR, Bhardwaj HL, Paulsen WHJ, Grizzard JD, Shah RD, Gertz ZM.

JACC Cardiovasc Interv. 2017 Nov 13;10(21):e195-e197. doi: 10.1016/j.jcin.2017.04.039. Epub 2017 Oct 18. No abstract available.

32.

Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.

Canada JM, Trankle CR, Buckley LF, Carbone S, Abouzaki NA, Kadariya D, Shah K, Cooke R, Kontos MC, Patel J, Mankad P, Schatz A, Bhatnagar A, Arena R, Van Tassell BW, Abbate A.

Am J Cardiol. 2017 Nov 15;120(10):1854-1857. doi: 10.1016/j.amjcard.2017.07.099. Epub 2017 Aug 7.

33.

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction.

Trankle C, Canada JM, Buckley L, Carbone S, Dixon D, Arena R, Van Tassell B, Abbate A.

ESC Heart Fail. 2017 Aug;4(3):351-355. doi: 10.1002/ehf2.12147. Epub 2017 May 6.

34.

Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.

Dixon DL, Buckley LF, Trankle CR, Kadariya D, Abbate A.

Drug Des Devel Ther. 2017 Jul 11;11:2121-2129. doi: 10.2147/DDDT.S114091. eCollection 2017. Review.

35.

Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).

Van Tassell BW, Buckley LF, Carbone S, Trankle CR, Canada JM, Dixon DL, Abouzaki N, Oddi-Erdle C, Biondi-Zoccai G, Arena R, Abbate A.

Clin Cardiol. 2017 Sep;40(9):626-632. doi: 10.1002/clc.22719. Epub 2017 May 5.

36.

Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2.

Messerer R, Dallanoce C, Matera C, Wehle S, Flammini L, Chirinda B, Bock A, Irmen M, Tränkle C, Barocelli E, Decker M, Sotriffer C, De Amici M, Holzgrabe U.

Medchemcomm. 2017 Apr 27;8(6):1346-1359. doi: 10.1039/c7md00149e. eCollection 2017 Jun 1.

37.

Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.

Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A.

J Am Coll Cardiol. 2016 Dec 6;68(22):2487-2488. doi: 10.1016/j.jacc.2016.08.072. No abstract available.

38.

Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation.

Trankle C, Thurber CJ, Toldo S, Abbate A.

JACC Basic Transl Sci. 2016 Oct 31;1(6):524-535. doi: 10.1016/j.jacbts.2016.06.012. eCollection 2016 Oct. Review.

39.

A review of PCSK9 inhibition and its effects beyond LDL receptors.

Dixon DL, Trankle C, Buckley L, Parod E, Carbone S, Van Tassell BW, Abbate A.

J Clin Lipidol. 2016 Sep-Oct;10(5):1073-80. doi: 10.1016/j.jacl.2016.07.004. Epub 2016 Jul 20. Review.

PMID:
27678423
40.

Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis.

Schatz A, Trankle C, Yassen A, Chipko C, Rajab M, Abouzaki N, Abbate A.

Int J Cardiol. 2016 Nov 15;223:215-216. doi: 10.1016/j.ijcard.2016.08.131. Epub 2016 Aug 7. No abstract available.

PMID:
27541656
41.

Autonomic instability and asystole: Broadening the differential diagnosis of cardiac arrhythmias.

Chawla R, Zukas AM, Pitcher JH, Trankle C, Brath L, Abbate A.

Int J Cardiol. 2016 Oct 1;220:665-7. doi: 10.1016/j.ijcard.2016.06.297. Epub 2016 Jun 29. No abstract available.

PMID:
27393847
42.

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.

Van Tassell BW, Abouzaki NA, Oddi Erdle C, Carbone S, Trankle CR, Melchior RD, Turlington JS, Thurber CJ, Christopher S, Dixon DL, Fronk DT, Thomas CS, Rose SW, Buckley LF, Dinarello CA, Biondi-Zoccai G, Abbate A.

J Cardiovasc Pharmacol. 2016 Jun;67(6):544-51. doi: 10.1097/FJC.0000000000000378.

43.

Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure.

Canada JM, Fronk DT, Cei LF, Carbone S, Erdle CO, Abouzaki NA, Melchior RD, Thomas CS, Christopher S, Turlington JS, Trankle CR, Thurber CJ, Evans RK, Dixon DL, Van Tassell BW, Arena R, Abbate A.

Am J Cardiol. 2016 Jan 1;117(1):116-20. doi: 10.1016/j.amjcard.2015.10.020. Epub 2015 Oct 19.

PMID:
26546248
44.

M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.

Keller M, Tränkle C, She X, Pegoli A, Bernhardt G, Buschauer A, Read RW.

Bioorg Med Chem. 2015 Jul 15;23(14):3970-90. doi: 10.1016/j.bmc.2015.01.015. Epub 2015 Jan 14.

PMID:
25650309
45.

Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies).

Abbate A, Kontos MC, Abouzaki NA, Melchior RD, Thomas C, Van Tassell BW, Oddi C, Carbone S, Trankle CR, Roberts CS, Mueller GH, Gambill ML, Christopher S, Markley R, Vetrovec GW, Dinarello CA, Biondi-Zoccai G.

Am J Cardiol. 2015 Feb 1;115(3):288-92. doi: 10.1016/j.amjcard.2014.11.003. Epub 2014 Nov 13.

PMID:
25482680
46.

Rational design of partial agonists for the muscarinic m1 acetylcholine receptor.

Chen X, Klöckner J, Holze J, Zimmermann C, Seemann WK, Schrage R, Bock A, Mohr K, Tränkle C, Holzgrabe U, Decker M.

J Med Chem. 2015 Jan 22;58(2):560-76. doi: 10.1021/jm500860w. Epub 2014 Dec 19.

PMID:
25478907
47.

Pilot the pulse: controlling the multiplicity of receptor dynamics.

Bock A, Kostenis E, Tränkle C, Lohse MJ, Mohr K.

Trends Pharmacol Sci. 2014 Dec;35(12):630-8. doi: 10.1016/j.tips.2014.10.002. Epub 2014 Oct 31.

PMID:
25455830
48.

Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison.

Otto R, Penzis R, Gaube F, Winckler T, Appenroth D, Fleck C, Tränkle C, Lehmann J, Enzensperger C.

Eur J Med Chem. 2014 Nov 24;87:63-70. doi: 10.1016/j.ejmech.2014.09.048. Epub 2014 Sep 16.

PMID:
25240096
49.

Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors.

Zlotos DP, Tränkle C, Holzgrabe U, Gündisch D, Jensen AA.

J Nat Prod. 2014 Sep 26;77(9):2006-13. doi: 10.1021/np500259j. Epub 2014 Sep 5.

50.

Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.

Schmitz J, van der Mey D, Bermudez M, Klöckner J, Schrage R, Kostenis E, Tränkle C, Wolber G, Mohr K, Holzgrabe U.

J Med Chem. 2014 Aug 14;57(15):6739-50. doi: 10.1021/jm500790x. Epub 2014 Aug 4.

PMID:
25051097

Supplemental Content

Loading ...
Support Center